Insights

Gathering insights about Fold…

Similar companies to Fold

Fold Tech Stack

Fold uses 8 technology products and services including Mixpanel, Parse.ly, Zendesk, and more. Explore Fold's tech stack below.

Mixpanel
Analytics
Parse.ly
Analytics
Zendesk
Documentation Tools
SOC 2
Governance, Risk And Compliance
AngularJS
Javascript Frameworks
Moment.js
Javascript Libraries
core-js
Javascript Libraries
jQuery
Javascript Libraries

Media & News

BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition
BioMarin Pharmaceutical remains a "Strong Buy," driven by pipeline progress, strategic acquisitions, and robust revenue guidance. BMRN's acquisition of Amicus Therapeutics adds GALAFOLD and POMBILITI + OPFOLDA, boosting 2026 revenue guidance to $3.825–$3.925 billion and targeting 20% YoY growth. VOXZOGO expansion into hypochondroplasia and ongoing clinical trials represent major catalysts, with topline Phase 3 data expected in Q2 2026.
May 06, 2026 | seekingalpha.com
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)
Amicus Therapeutics targets rare genetic diseases with proprietary therapies and a pipeline of treatments for underserved patient groups.
Apr 25, 2026 | www.fool.com
BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy
BioMarin (BMRN) has declined over 12% since January 2025, despite prior optimism. The investment thesis centers on the potential of VOXZOGO and Amicus's two approved therapies to drive future upside. Current share weakness may present a buying opportunity given VOXZOGO's prospects.
Apr 15, 2026 | seekingalpha.com
SG Americas Securities LLC Acquires 36,938 Shares of Amicus Therapeutics, Inc. $FOLD
SG Americas Securities LLC boosted its holdings in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 53.2% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 106,358 shares of the biopharmaceutical company's stock after buying an additional 36,938 shares during the
Apr 07, 2026 | www.defenseworld.net
Capricorn Fund Managers Ltd Invests $3 Million in Amicus Therapeutics, Inc. $FOLD
Capricorn Fund Managers Ltd bought a new stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 210,674 shares of the biopharmaceutical company's stock, valued at approximately $3,000,000. Capricorn Fund Managers Ltd
Apr 06, 2026 | www.defenseworld.net
Leading Financial Trade Associations, Led by LSTA, Submit Amicus Brief in Support of Defendant Lenders in Antitrust Case Filed by Optumum Communications
NEW YORK--(BUSINESS WIRE)--LSTA, the trade association for the U.S. corporate lending market, today was joined by SIFMA, the MFA, the Investment Company Institute and the Creditor Rights Coalition, in submitting an amicus brief in support of the defendant lenders in a misguided antitrust case filed by Optimum Communications, Inc. The complaint, one of the first of its kind, is an attempt to apply traditional antitrust principles to “Cooperation Agreements”, which have grown increasingly common.
Mar 26, 2026 | www.businesswire.com
Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD
Avoro Capital Advisors LLC reduced its stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 16.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,025,000 shares of the biopharmaceutical company's stock after selling 2,975,000 shares during the period.
Mar 14, 2026 | www.defenseworld.net

Fold's Email Address Formats

Fold uses at least 1 format(s):

Fold Email Formats	Example	Percentage
Last@foldapp.com	Doe@foldapp.com	62%
First.Last@foldapp.com	John.Doe@foldapp.com	21%
First@foldapp.com	John@foldapp.com	13%
FLast@foldapp.com	JDoe@foldapp.com	4%

Frequently Asked Questions

Where is Fold's headquarters located?

Fold's main headquarters is located at 11201 North Tatum Boulevard Suite 300 #42035 Phoenix, Arizona United States. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Fold's stock symbol?

Fold is a publicly traded company; the company's stock symbol is FOLD.

What is Fold's official website and social media links?

Fold's official website is foldapp.com and has social profiles on LinkedIn.

What is Fold's NAICS code?

Fold's NAICS code is 52 - Finance and Insurance.

How many employees does Fold have currently?

As of June 2026, Fold has approximately 50 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Ceo & Cofounder: W. R.Head Of Marketing (growth + Product Marketing): A. A.Cofounder: C. P.. Explore Fold's employee directory with LeadIQ.

What industry does Fold belong to?

Fold operates in the Financial Services industry.

What technology does Fold use?

Fold's tech stack includes MixpanelParse.lyZendeskSOC 2AngularJSMoment.jscore-jsjQuery.

What is Fold's email format?

Fold's email format typically follows the pattern of Last@foldapp.com. Find more Fold email formats with LeadIQ.

When was Fold founded?

Fold was founded in 2014.

Fold

Q: What is Fold's official website and social media links?

Fold's official website is foldapp.com. Fold has social profiles on LinkedIn.

Q: How many employees does Fold have currently?

Fold has approximately 50 employees.

Q: What technology does Fold use?

Fold's tech stack includes SOC 2, Moment.js, iCIMS, Font Awesome, Segment.

Q: What is Fold's NAICS code?

Fold's NAICS code is 52 (Finance and Insurance).

Financial ServicesArizona, United States11-50 Employees

Fold is a financial services company headquartered in Phoenix, Arizona, United States, located at 11201 North Tatum Boulevard Suite 300 #42035. It employs between 11 and 50 people. Fold focuses on personal finance solutions that integrate bitcoin with banking features. The company operates a website at foldapp.com.

Company Overview

Headquarters: 11201 North Tatum Boulevard Suite 300 #42035 Phoenix, Arizona United States
Website: foldapp.com
Stock Symbol: FOLD
NAICS Code: 52 - Finance and Insurance
Founded: 2014
Employees: 11-50

Media & News

Funding & Financials

$25M$50M
Fold's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
Fold's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Fold

Spin (Ford Mobility)

Bitrefill

Gemini

Bitnovo

Flexa

Purse

Bitwala

Fold

Square

BitPay

Change

Rakuten

Xapo

Lolli

Fold Tech Stack

Media & News

BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition

CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)

BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy

SG Americas Securities LLC Acquires 36,938 Shares of Amicus Therapeutics, Inc. $FOLD

Capricorn Fund Managers Ltd Invests $3 Million in Amicus Therapeutics, Inc. $FOLD

Leading Financial Trade Associations, Led by LSTA, Submit Amicus Brief in Support of Defendant Lenders in Antitrust Case Filed by Optumum Communications

Avoro Capital Advisors LLC Decreases Stock Holdings in Amicus Therapeutics, Inc. $FOLD

Fold's Email Address Formats

Frequently Asked Questions

Where is Fold's headquarters located?

What is Fold's stock symbol?

What is Fold's official website and social media links?

What is Fold's NAICS code?

How many employees does Fold have currently?

What industry does Fold belong to?

What technology does Fold use?

What is Fold's email format?

When was Fold founded?

Fold

Company Overview

Media & News

BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition

CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)

BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?